Effects of Neonatal Stress and Morphine on Kappa Opioid Receptor Signaling
Author(s) -
Thuy N. Vien,
Christine A. Gleason,
Sarah L. Hays,
Ronald J. McPherson,
Charles Chavkin,
Sandra E. Juul
Publication year - 2009
Publication title -
neonatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.399
H-Index - 84
eISSN - 1661-7819
pISSN - 1661-7800
DOI - 10.1159/000220763
Subject(s) - dynorphin , morphine , κ opioid receptor , gliosis , opioid , medicine , endocrinology , hippocampal formation , receptor , pharmacology , opioid peptide , pathology
Critically ill neonates experience multiple stressors during hospitalization. Opioids are commonly prescribed to ameliorate their pain and stress. However, the enduring effects of stress and opioids are not understood. The kappa opioid system is important in the mediation of stress in adults, but little is known about its function in neonates.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom